Radiology devices branch on the move
This article was originally published in The Gray Sheet
Executive Summary
FDA's Radiological Devices Branch is moving from its current home in the Office of Device Evaluation to the Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD), FDA says. One of the center's largest review branches, the radiological devices office encompasses diagnostic devices such as x-ray and magnetic resonance imaging equipment, as well as non-diagnostic products such as radiofrequency ablation catheters and cancer radiation treatments. The branch is expected to retain its current personnel, according to a member of the Radiological Society of North America
You may also be interested in...
Radiology Devices Move To OIVD: More Cohesive Dx Reviews Ahead?
FDA hopes that shuttling its Radiological Devices Branch to the Office of In Vitro Diagnostic Device Evaluation and Safety will produce more cohesive policies on diagnostic device review
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.